Drugs / Enalapril Orodispersible Minitablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02652741 | Jan 2016 → Jun 2017 | congenital heart disease, heart failure | Ethicare GmbH | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enalapril Orodispersible Minitablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02652741 ↗ |